Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Renalytix AI (RNLX) has shared an announcement.
Renalytix plc issued convertible bonds worth $21.2 million in April 2022, attracting interest at 5.5% annually, with the possibility of repaying in cash or shares. Starting July 2022, they began repaying in equal quarterly installments. By April 2024, they plan to issue over 3.6 million shares to settle a portion of the debt, reducing the principal by $1.06 million. The company has announced this repayment through a press release, clarifying that the announcement is not considered legally filed but is for informational purposes only.
For a thorough assessment of RNLX stock, go to TipRanks’ Stock Analysis page.
